Sales and Marketing

Showing 15 posts of 11524 posts found.

Biogen submits Fampridine PR to European regulators

January 14, 2010 Sales and Marketing Biogen, Fampridine, MS

Biogen Idec is seeking European approval for a drug which helps multiple sclerosis sufferers to walk better. A marketing authorisation …

Hans Regenauer joins Sanofi-Aventis’ consumer division

January 14, 2010 Sales and Marketing Sanofi-Aventis, appointment, consumer healthcare, sales and marketing

Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …
GSK's swine flu vaccine Pandemrix

Germany cuts GSK swine flu vaccine orders by 30%

January 13, 2010 Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1, swine flu

The Germany Ministry of Health has cut its order for GlaxoSmithKline’s swine flu vaccine Pandemrix by 30%. The pharma company …

FDA begins consumer transparency initiative

January 13, 2010 Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

Train to retain: holding onto your best people

January 13, 2010 Business Services, Sales and Marketing MSI, careers, training

It’s a widely-held myth that retaining staff is easy in a recession. As jobs are cut the attraction of staying …

Novartis launches Ilaris in the UK

January 12, 2010 Sales and Marketing Ilaris, Novartis, cryopyrin-associated periodic syndrome

Novartis has launched its new biologic Ilaris in the UK as a treatment for cryopyrin-associated periodic syndrome. The rare debilitating …

FDA approves Roche’s Actemra

January 11, 2010 Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis

Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …

Alison Clough promoted to commercial and communications director for the ABPI

January 11, 2010 Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …

NICE says no to Multaq

January 8, 2010 Sales and Marketing Multaq, NICE, Sanofi

NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …
b-angelici-72dpi

AstraZeneca’s Bruno Angelici awarded Légion d`honneur

January 8, 2010 Sales and Marketing AstraZeneca, France, appointment, sales and marketing

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …
GP writing prescription

England moves forward on generic substitution

January 8, 2010 Sales and Marketing NHS, generics, substitution

The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010 Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
US healthcare reform demonstrators

Pharma welcome for Senate healthcare reform vote

January 6, 2010 Sales and Marketing Obama, Senate, US healthcare

Pharma manufacturers have welcomed the passing of the US Senate’s healthcare reform bill on Christmas Eve. Ken Johnson, senior vice …

Alcon directors protest Novartis takeover bid

January 6, 2010 Research and Development, Sales and Marketing Alcon, Novartis

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
JGerberding_cdc_photo

Dr Julie Gerberding appointed to head up Merck Vaccines

January 6, 2010 Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
The Gateway to Local Adoption Series

Latest content